Centaurus Financial, Inc. Brainstorm Cell Therapeutics Inc. Transaction History
Centaurus Financial, Inc.
- $1.37 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding BCLI
# of Institutions
51Shares Held
4.03MCall Options Held
63.2KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA1.4MShares$490,3470.0% of portfolio
-
Black Rock Inc. New York, NY489KShares$171,2590.0% of portfolio
-
Geode Capital Management, LLC Boston, MA357KShares$124,9640.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA340KShares$119,0520.04% of portfolio
-
Weaver Consulting Group234KShares$82,0240.03% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $12.8M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...